Citadel Advisors
IQMDW

Citadel Advisors’s Intelligent Medicine Acquisition Corp. Warrant IQMDW Stock Holding History

Citadel Advisors’s Portfolio IQMDW Stock Details IQMDW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-300,000
Closed -$83K – 14613
2022
Q1 		$83K Hold
300,000
– – ﹤0.01% 12455
2021
Q4 		$147K Buy
+300,000
New +$151K ﹤0.01% 12290

Other funds holding IQMDW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Citadel Advisors's IQMDW Position: Q2 2022 in Review

Citadel Advisors sold out of Intelligent Medicine Acquisition Corp. Warrant (IQMDW) in Q2 2022, closing a stake of 300,000 shares — an estimated $83K sold.

Citadel Advisors first reported a position in IQMDW in Q4 2021 and held it in 2 quarters. The position peaked at $147K in Q4 2021. 42 funds tracked by Wall St. Rank hold IQMDW as of Q2 2022.

  • Citadel Advisors reported no remaining Intelligent Medicine Acquisition Corp. Warrant position as of Q2 2022 after selling out during the quarter.
  • Citadel Advisors sold 300,000 Intelligent Medicine Acquisition Corp. Warrant shares in Q2 2022, an estimated $83K.
  • Citadel Advisors first reported a position in Intelligent Medicine Acquisition Corp. Warrant in Q4 2021 and held it in 2 quarters.
  • Citadel Advisors's Intelligent Medicine Acquisition Corp. Warrant position peaked at $147K in Q4 2021.
  • 42 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Warrant as of Q2 2022.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.